HIGHLIGHTS
- who: Nhu Hanh To and colleagues from the Department of Radiation Oncology and The Henri Mondor Center, Henri Mondor University Hospital, Research (IMRB), University of Paris-Est Creteil (UPEC), Creteil, France have published the Article: Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial, in the Journal: (JOURNAL)
- what: The authors aimed to evaluate immunity-related indicators of response to chemoradiation therapy (NACRT) in BC for better treatment personalization. The study showed the same tendency of tumor response by subtypes; 38% and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.